AEHR

In April 2026, Aehr's stock surged 144.2% due to a record $41 million production order from a hyperscale cloud customer for package-level burn-in systems for custom AI processor chips, including Sonoma high-end testing systems and burn-in modules, with deliveries expected in fiscal year 2027. This order pushed second-half bookings above $92 million. In July 2026, Aehr reported record fiscal 2026 fourth-quarter bookings of $60.7 million and an effective backlog of $100.6 million. Despite a decrease in fiscal 2026 revenue to $50.0 million from $59.0 million in 2025, the company projected fiscal 2027 revenue of $130 million to $150 million, driven by demand from AI processors, silicon photonics, and power semiconductors. In August 2026, Aehr received a follow-on production order from its lead silicon photonics wafer-level burn-in customer for a fully automated FOX-XP multi-wafer production burn-in system. Most recently, on October 7, 2026, Aehr announced approximately $6 million in follow-on production orders from its primary hyperscale customer for Sonoma high-power testing systems and turnkey burn-in modules for advanced AI processors, with deliveries scheduled over the next six months to an OSAT partner in Taiwan. This order is for a second AI device from the customer, expected to ramp up production in calendar 2027. Analyst sentiment is generally positive, with a 'Moderate Buy' consensus and an average price target of $132.50 as of October 2026, though Zacks Research downgraded the stock to a 'hold' in September 2026. Insider selling totaling $62.7 million over the past 12 months indicates cautious insider sentiment.